Glass House Brands Reports Mixed Q2 2026 Results Amid Strategic Restructuring — Glass House Brands Inc.

Event summary

Glass House Brands reported Q2 2026 revenue of $47.0 million, down slightly from $47.6 million in Q2 2025 but up from $28.6 million in Q1 2026.
The company achieved record biomass production of 246,000 pounds at a cost of $122 per pound, showing significant improvement from the previous quarter's $175 per pound.
Glass House completed the deconsolidation of its retail operations and uplisted to the NYSE.
Adjusted EBITDA turned positive at $5.7 million, compared to a loss of $(4.2) million in Q1 2026.

The big picture

Glass House Brands is navigating a complex transition, streamlining its operations to focus on medically licensed and Schedule III compliant business segments. The company's strategic moves, including DEA registration and NYSE uplisting, position it to capitalize on potential interstate commerce opportunities. However, the mixed financial results highlight the challenges of operating in California's competitive cannabis market.

What we're watching

Production Efficiency: Whether Glass House can sustain its improved production costs and scale up to its full-year forecast of 1 million pounds of biomass.
Regulatory Compliance: How the company's DEA-registered licenses will position it for interstate commerce and international medical cannabis markets.
Financial Health: The impact of the retail deconsolidation on Glass House's financial flexibility and strategic focus.